Clinical Trials Browser

Phase 1/2 × Disease Progression × Other hematologic neoplasm × Clear all

NCT07109323 2025-08-07

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Phase 1/2 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Disease Progression

NCT04029038 2023-08-21

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual, Disease Progression